Navigation Links
Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project

CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health's flagship project working to strengthen health systems by using an integrated approach to address the financing, governance, operational, and capacity constraints to further the use of life-saving priority health services.

Lion Coleman comes to Abt Associates from the Office of the Global AIDS Coordinator (OGAC) where she served as Technical Support Coordinator for the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), as well as United States Government (USG) delegate to the Global Fund Board of Directors.

She has 30 years of experience as a leader and manager of global, regional, and country-level health programs both internationally and domestically. At OGAC, Lion Coleman managed a $30 million portfolio of USG Global Fund technical support contracts and grants with UNAIDS, Roll Back Malaria, Stop TB, Green Light Committee, and Management Sciences for Health.

"We are delighted that Ann is joining us as HS 20/20 expands and moves into its third year. Her experience with the major actors is particularly valuable as international attention to health systems issues increases," said Nancy Pielemeier, Vice President for International Health at Abt Associates.

Previously Lion Coleman worked as Senior Health Advisor for USAID's office of Population and Reproductive Health. She managed the Agency's bureau-wide Capacity Project; oversaw the $250 million portfolio focusing on the strengthening and integration of health systems at a global level; and directed project staffing, strategic planning, and linkages with other global efforts including those at WHO and the World Bank. She also managed USAID's YouthNet project, guiding global activities to improve the reproductive health and HIV/AIDS prevention behaviors of youth. Earlier as Senior Management Advisor at the Program for Appropriate Technology in Health (PATH), she spent seven years as the regional director for Latin America and the Caribbean where she led efforts to improve performance of health care providers in a number of LAC countries.

"I am enthusiastic about joining Abt and USAID's flagship project HS 20/20. We are at a critical time to focus on health system strengthening. As both PEPFAR and the Global Fund efforts reach their next phase of implementation, health systems strengthening is a key priority to the success of the disease-specific global efforts," Lion Coleman explained.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.

SOURCE Abt Associates
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
2. Front Line Caregiver Coalition Thanks Sens. Conrad, Coleman and Reps. Pomeroy, Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Administrations Damaging Medicare Cuts
3. Richard Greco Joins Mediware Board
4. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
5. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
6. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
7. Nick Childs Joins Grey New York as Director of Content Development
8. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
9. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
10. NASN Joins Partnership to Fight Chronic Disease
11. AstraZeneca Joins Local Walking Movement
Post Your Comments:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology: